Andrea J Vernall

Years Active: 2018-2023
Publications (10 Years): 5

University of Canterbury (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Canterbury Mar 1o 2002 - Sep 1o 2005

New Zealand

PHD :: Department of Chemistry

Publications

Raahul Sharma, Sameek Singh, Zak M Whiting, Maximilian Molitor, Andrea J Vernall, Natasha L Grimsey
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International journal of molecular sciences 24 (7) (2023)
Ian Liddle, Michelle Glass, Joel D A Tyndall, Andrea J Vernall
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges. RSC medicinal chemistry 13 (5) (2022)
Phuc N H Trinh, Daniel J W Chong, Katie Leach, Stephen J Hill, Joel D A Tyndall, Lauren T May, Andrea J Vernall, Karen J Gregory
Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors. Journal of medicinal chemistry 64 (12) (2021)
Sameek Singh, Samantha L Cooper, Jacqueline R Glenn, Jessica Beresford, Lydia R Percival, Joel D A Tyndall, Stephen J Hill, Laura E Kilpatrick, Andrea J Vernall
Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools. RSC advances 8 (29) (2018)
Anna G Cooper, Caitlin R M Oyagawa, Jamie J Manning, Sameek Singh, Sarah Hook, Natasha L Grimsey, Michelle Glass, Joel D A Tyndall, Andrea J Vernall
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. MedChemComm 9 (12) (2018)

Andrea J Vernall.css-eqlu8i{font-size:small;padding-left:4px;}